Mivtachim The Workers Social Insurance Fund’s Evogene EVGN Stock Holding History

Mivtachim The Workers Social Insurance Fund’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,627	Closed	-$431K	–	25
2016 Q1	$431K	Sell	6,627 -11,273	-63%	-$774K	0.03%	25
2015 Q4	$1.44M	Hold	17,900	–	–	0.11%	22
2015 Q3	$1.48M	Hold	17,900	–	–	0.14%	19
2015 Q2	$1.58M	Hold	17,900	–	–	0.15%	22
2015 Q1	$1.58M	Hold	17,900	–	–	0.13%	23
2014 Q4	$1.65M	Hold	17,900	–	–	0.15%	23
2014 Q3	$2.36M	Buy	+17,900	New	+$2.47M	0.25%	20

Other funds holding EVGN

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Mivtachim The Workers Social Insurance Fund's EVGN Position: Q2 2016 in Review

Mivtachim The Workers Social Insurance Fund sold out of Evogene (EVGN) in Q2 2016, closing a stake of 6,627 shares — an estimated $431K sold.

Mivtachim The Workers Social Insurance Fund first reported a position in EVGN in Q3 2014 and held it in 7 quarters. The position peaked at $2.36M in Q3 2014. 18 funds tracked by Wall St. Rank hold EVGN as of Q2 2016.

Mivtachim The Workers Social Insurance Fund reported no remaining Evogene position as of Q2 2016 after selling out during the quarter.
Mivtachim The Workers Social Insurance Fund sold 6,627 Evogene shares in Q2 2016, an estimated $431K.
Mivtachim The Workers Social Insurance Fund first reported a position in Evogene in Q3 2014 and held it in 7 quarters.
Mivtachim The Workers Social Insurance Fund's Evogene position peaked at $2.36M in Q3 2014.
18 funds tracked by Wall St. Rank held Evogene as of Q2 2016.

Based on Mivtachim The Workers Social Insurance Fund's 13F filing for Q2 2016, filed 20 Jul 2016.